Schiró R, Coutinho L H, Will A, Chang J, Testa N G, Dexter T M
Department of Experimental Haematology, Paterson Laboratories, Christie Hospital and Holt Radium Institute, Manchester, UK.
Blut. 1990 Nov;61(5):267-70. doi: 10.1007/BF01732875.
The ability of the in vitro long-term bone marrow culture (LTBMC) system to impair the survival of leukemic cells and to enhance the growth of normal progenitors has been studied. Bone marrow cells from 19 acute lymphoblastic leukemia (ALL) and 30 acute myeloid leukemia (AML) patients at diagnosis were grown in LTBMC for 4-10 weeks. In half of the cases the leukemic population declined down to undetectable levels and was replaced by putative normal hemopoietic precursors, both in ALL and in AML. In the remaining cases, leukemic cells persisted throughout the culture time and few if any normal hemopoietic cells were detected. These data led us to extend to the lymphoid compartment the previous observation of decreasing leukemic myeloid blasts in LTBMC. The potential of such cultures as an in vitro purging system for autologous bone marrow transplantation in selected poor-prognosis lymphoid malignancies should be explored, as has been done for acute and chronic myeloid leukemias.
体外长期骨髓培养(LTBMC)系统损害白血病细胞存活并促进正常祖细胞生长的能力已得到研究。19例急性淋巴细胞白血病(ALL)和30例急性髓细胞白血病(AML)患者诊断时的骨髓细胞在LTBMC中培养4至10周。在半数病例中,白血病细胞群下降至检测不到的水平,并被假定的正常造血前体细胞取代,ALL和AML均如此。在其余病例中,白血病细胞在整个培养期间持续存在,几乎未检测到正常造血细胞。这些数据使我们将之前在LTBMC中白血病髓系母细胞减少的观察结果扩展至淋巴系。应探索此类培养物作为体外净化系统用于选定预后不良的淋巴系恶性肿瘤自体骨髓移植的潜力,就像对急性和慢性髓细胞白血病所做的那样。